Investor
Ideas #Potcasts; #Cannabis News and #Stocks on the Move; (OTCQB: $PBIO), (TSX: $TRST.TO)
(NYSE: $CTST) (TSXV: $NDVA.V)
(TSXV: $JWCA.V)
Delta, Kelowna, BC, February 28, 2020 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast
edition of cannabis news and
stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/02281PBIO-TRST-CTST-NDVA-JWCA.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public announcements.
Pressure
BioSciences, Inc. (OTCQB:
PBIO), a leader in the development and sale of broadly
enabling, pressure-based instruments, consumables, and platform technology
solutions to the worldwide biotechnology, biotherapeutics, and other
industries, announced the
official opening of its new Ultra Shear Technology™ ("UST™")
Demonstration Laboratory. The UST Demo
Lab is located in the Company's South Easton, Massachusetts facility.
A
major purpose of the UST Demo Lab is to showcase the ability of the Company's
revolutionary UST Platform to process CBD oil into true, high quality,
water-soluble nanoemulsions. It is expected that nanoemulsions of CBD will be
more stable, have superior aesthetic quality, and offer higher bioavailability
than the standard macro/microemulsions used in most CBD products today
(Nanoemulsions, in Handbook of Nanomaterials in Industrial Applications,
Ghodake and Patravale, 2018). A second
purpose is to invite potential purchasers of the Company's UST-based BaroShear
Systems (initial release expected Q4 2020) to evaluate how their CBD and other
product formulations work with the Company's revolutionary UST platform.
This
Company today released a new short video demonstrating how CBD oil from an
independent manufacturer was processed into a clear, water-soluble nanoemulsion
using a UST-based, first generation BaroShear system. The video shows the CBD
oil and water mixture prior to and after UST processing.
Kenneth
F. Micciche, Director of PBI's UST Program, said: "We processed samples of
CBD oil formulations from several highly interested companies over the past two
months, in an effort to optimize the service we announced today. The results speak for themselves: one group
(Vegas CBD Factory) ordered six BaroShear K45 systems (for Q4 2020 delivery and
installation). We believe several more
companies who participated in the early evaluation process are close to giving
us their purchase orders. The ability to
showcase the UST platform in real life, and see the final product first-hand,
has been shown to be vital to our marketing efforts. As has been said in the past: 'build it and
they will come'. The opening of the UST Demo Lab is a critical accomplishment
in our UST sales and marketing strategy."
Richard
T. Schumacher, President and CEO of PBI commented: "The initial reactions
from manufacturers of topical and ingestible cannabidiol products processed in
our lab during the trial period have been extremely positive. They quickly saw
how they could realize substantial cost reductions while eliminating the
overloading of poorly water-soluble CBD and other cannabinoids into products to
achieve targeted dosing levels. We believe our breakthrough technology platform
provides them with a new-found ability to provide safe and effective dosing for
their customers, which in turn should stimulate greater growth in the market
for CBD-based products overall, and strong sales of our BaroShear product line
when it is released to the market later this year."
CannTrust Holdings
Inc.
(TSX:
TRST) (NYSE:
CTST) announced that on
February 27, 2020 the Company received written notification from the New York
Stock Exchange that CannTrust is no longer in compliance with the NYSE's
continued listing standard rules because the per share trading price of the
Company's common shares has fallen below the NYSE's share price rule. The NYSE requires the average closing price
of a listed company's common shares to be at least US $1.00 per share over a
consecutive 30 trading-day period. As of February 25, 2020, the 30 trading-day
average closing price of the Company's common shares was US $0.99.
In
accordance with the NYSE's rules, CannTrust has six months from the receipt of
the notice to regain compliance. During this time period, the Company's common
shares will continue to be listed and trade on the NYSE as usual.
Under
NYSE rules, CannTrust can regain compliance at any time during the six-month
period if its common shares have a closing price of at least US $1.00 on the
last trading day of any calendar month during the period and also have an
average closing price of at least US $1.00 over the 30 trading-day period
ending on the last trading day of that month or on the last day of the cure
period.
Indiva Limited (TSXV:NDVA) (OTCQX:NDVAF) and Lift & Co. Corp. (TSXV:LIFT) (OTCQB:LFCOF) announced the
release of Indiva’s CannSell branded education module. The CannSell
certification program, created by Lift & Co., in exclusive partnership with
MADD Canada, is currently utilized in eight Canadian jurisdictions. CannSell
also serves as the provincially-mandated training program for all cannabis
retail workers in Ontario. These frontline staff members are responsible for
educating consumers on the safe use of cannabis where it is sold. The Indiva
education experience on the CannSell platform offers an overview of the
Company, its product portfolio, and its commitment to quality, innovation and
sustainability.
“We
are proud to partner with Lift & Co. in educating this important community
about Indiva and our products,” Niel Marotta, Indiva’s President and Chief
Executive Officer, said. “Many consumers do not know what to purchase prior to
entering a store. Budtenders are a great first point of contact for those
interested in learning more about cannabis. Their guidance makes cannabis more
accessible and helps Canadians make informed decisions. We look forward to
staying connected to the budtender community and working in partnership with
organizations like Lift & Co. to educate the public about cannabis,
cannabis products and responsible use.”
“Through
the CannSell platform, Lift & Co. is able to support brands like Indiva to
deliver brand education directly to Canadian budtenders who are critical to
consumers’ cannabis education and eventual purchase decisions,” Matei Olaru,
CEO of Lift & Co., said. “Whether it’s through this platform, lift.co or Cohesion, Lift & Co.’s
entire platform connects brands like Indiva to consumers through several key
touchpoints.”
James E. Wagner
Cultivation Corporation (TSXV:
JWCA.V) (OTCQX:
JWCAF) announced that it
has entered into a Memorandum of Understanding with CannNext BV, a company
based in Amsterdam, the Netherlands, pursuant to which JWC will assist CannNext
with its tender to the Government of the Netherlands for a licence to produce
medical cannabis in the Netherlands.
In
support of CannNext’s Tender, JWC has provided certain necessary commitments
and attestations required by the Government of the Netherlands. In addition, in
connection with the Tender process and, if the Tender is successful, the
resulting anticipated production of medical cannabis in the Netherlands, JWC
will provide CannNext with industry knowledge and experience related to the
cultivation and production of medical cannabis for a consumer market.
The
MOU outlines the parties’ intention to collaborate in developing cannabis
cultivation best-practices. This will involve research and development related
to strains, grow methods and lighting practices. JWC and CannNext also intend
to negotiate a definitive agreement pursuant to which CannNext will agree to
represent JWC in the Netherlands and the European Union for licensing of JWC’s
GrowthSTORM™ technology. JWC will also acquire a minority equity position in
CannNext.
CannNext
is focused on the research and
development related to improving yields for controlled medical cannabis
cultivation both for and with its own clients. CannNext’s state-of-the-art
government licensed, research facility is also located in the Netherlands, and
can be immediately converted to production.
“We
believe that shaping alliances with companies that focus on high-end medical
cannabis will benefit both parties to realize a global reach and leverage
combined knowledge”, says Eric Uleman, managing director of CannNext.
“Combining the long-standing cultivation knowledge of JWC and our focus on
light and grow strategies, will result in increasing our chances of becoming a
winner in the Dutch tender. We visited the JWC site at 530 Manitou Drive,
Kitchener, Ontario, and found that it aligns with our view of how a
best-in-class indoor facility would look. JWC delivers the best medical product
for patients driven by personal passion and its advanced cultivation
technology.”
“Our
proprietary GrowthSTORM™ technology is the foundation for our success here in
Canada,” says Nathan Woodworth, CEO and President of JWC. We believe by sharing
our technology and knowledge with CannNext, we will establish an important
gateway to the European Union Market. The Netherlands has reputation for being
a frontrunner in medical cannabis and represents one of the largest
recreational markets in the world.”
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration
Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
